Treatment of canine sarcoptic mange with afoxolaner (NexGard(®)) and afoxolaner plus milbemycin oxime (NexGard Spectra(®)) chewable tablets: efficacy under field conditions in Portugal and Germany

The efficacy of NexGard(®) and NexGard Spectra(®) against sarcoptic mange in dogs was evaluated in a clinical field study. Skin scrapings from dogs presenting signs suggestive of sarcoptic mange were examined to confirm infestation. A total of 106 dogs were screened at eight sites in Portugal and Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Hampel, Verena, Knaus, Martin, Schäfer, Jürgen, Beugnet, Frederic, Rehbein, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280674/
https://www.ncbi.nlm.nih.gov/pubmed/30516132
http://dx.doi.org/10.1051/parasite/2018064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280674/
https://www.ncbi.nlm.nih.gov/pubmed/30516132
http://dx.doi.org/10.1051/parasite/2018064

Ejemplares similares